1. Home
  2. IOBT

IOBT

IO Biotech Inc.

Logo IO Biotech Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Founded: 2014 Country:
Denmark
Denmark
Employees: N/A City: COPENHAGEN
Market Cap: 104.1M IPO Year: 2021
Target Price: $8.33 AVG Volume (30 days): 140.8K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.98 EPS Growth: N/A
52 Week Low/High: $0.82 - $2.64 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: